Perspective
Published on 18 May 2023
Novel insights into cancer stem cells targeting: CAR-T therapy and epigenetic drugs as new pillars in cancer treatment
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2023.1120090
Volumes
48 Publications
Volume 3 - 2023
Original Research
Published on 18 May 2023
Phase I-II study using DeltaRex-G, a tumor-targeted retrovector encoding a cyclin G1 inhibitor for metastatic carcinoma of breast
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2023.1105680
Original Research
Accepted on 12 May 2023
Energy-based Generative Models for Target-specific Drug Discovery
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2023.1160877
Mini Review
Accepted on 09 May 2023
Muscle-derived exosomes and exercise in cancer prevention
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2023.1202190
Original Research
Published on 20 Apr 2023
Biomechanical and biochemical assessment of YB-1 expression in A375 melanoma cell line: Exploratory study
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2023.1050487
- 243 views
Review
Published on 03 Apr 2023
Gene transfer and genome editing for familial hypercholesterolemia
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2023.1140997
- 526 views
Review
Published on 31 Mar 2023
Gene therapy and genome editing for type I glycogen storage diseases
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2023.1167091
- 510 views
Original Research
Accepted on 28 Mar 2023
Whole Genome Sequencing for Metastatic Mutational Burden in Extraskeletal Myxoid Chondrosarcoma
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2023.1152550
Perspective
Published on 23 Mar 2023
Human brain organoid code of conduct
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2023.1143298
- 629 views
Review
Published on 28 Feb 2023
The advent of a pan-collagenous CLOVIS POINT for pathotropic targeting and cancer gene therapy, a retrospective
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2023.1125928
- 205 views
Brief Research Report
Published on 22 Feb 2023
MCM10 expression is linked to cervical cancer aggressiveness
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2023.1009903
- 414 views
Original Research
Published on 22 Feb 2023
Using the Jurkat reporter T cell line for evaluating the functionality of novel chimeric antigen receptors
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2023.1070384
- 775 views
Review
Published on 17 Feb 2023
Cancer immunotherapies: A hope for the uncurable?
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2023.1140977
- 559 views
Review
Published on 16 Feb 2023
The Fault in Our Astrocytes - cause or casualties of proteinopathies of ALS/FTD and other neurodegenerative diseases?
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2023.1075805
- 556 views
Original Research
Published on 03 Feb 2023
Definition of a microbial signature as a predictor of endoscopic post-surgical recurrence in patients with Crohn’s disease
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2023.1046414
- 566 views
Review
Published on 23 Jan 2023
Why should we care about astrocytes in a motor neuron disease?
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2023.1047540
- 1,000 views